Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07460362
What this trial is testing

Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
MCLRelapsed or Refractory Mantle Cell Lymphoma (MCL)
Peking University Third Hospital 43
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT05140382
What this trial is testing

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

Who this might be right for
Relapsed/Refractory Peripheral T-cell LymphomaRelapsed/Refractory Classical Hodgkins Lymphoma
AstraZeneca 52
Early research (Phase 1)Looking for participantsNCT05741359
What this trial is testing

The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Bioray Laboratories 18
Early research (Phase 1)Looking for participantsNCT06696846
What this trial is testing

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory T-cell LymphomaRelapsed/Refractory Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Early research (Phase 1)Active Not RecruitingNCT02992522
What this trial is testing

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Lymphoma, UnspecifiedGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+10 more
Beth Christian 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702851
What this trial is testing

Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

Who this might be right for
Diffuse Large B-cell Lymphoma
Yonsei University 47
Early research (Phase 1)UnknownNCT02968472
What this trial is testing

A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia
The First People's Hospital of Yunnan 30
Testing effectiveness (Phase 2)UnknownNCT02955628
What this trial is testing

RICE-ibrutinib in Relapsed DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Recurrent
Singapore General Hospital 34
Early research (Phase 1)Looking for participantsNCT04892277
What this trial is testing

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+5 more
Mayo Clinic 25
Early research (Phase 1)Study completedNCT03305445
What this trial is testing

Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Icahn School of Medicine at Mount Sinai 6
Testing effectiveness (Phase 2)Study completedNCT00303953
What this trial is testing

PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT01134575
What this trial is testing

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT02340936
What this trial is testing

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 53
Early research (Phase 1)Ended earlyNCT00005787
What this trial is testing

Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNeutropenia
Northwestern University 3
Testing effectiveness (Phase 2)UnknownNCT04379167
What this trial is testing

Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd. 140
Next Page